ReviewInternational journal of nanomedicine2026
Nanomaterial-Based Photothermal Therapy for Inflammatory Diseases: Intervention Strategies, Synergistic Effects, and Future Challenges.
Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As a fundamental host defense mechanism, the transition from acute to chronic inflammation serves as the foundation for numerous major diseases. Conventional anti-inflammatory interventions are frequently hindered by inadequate bioavailability, instability, and undesirable side effects. High-temperature photothermal therapy (PTT) based on nanomaterials inhibits inflammatory cascades via the precise ablation of activated inflammatory cells, induction of apoptosis, bacterial elimination, and controlled drug release at lesion sites. Meanwhile, mild PTT exerts anti-inflammation through immunomodulation, including regulation of M1/M2 macrophage polarization and upregulation of heat shock proteins (HSPs). These two PTT modalities are complementary in anti‑inflammatory applications, providing more adaptable strategies for precision therapy of inflammatory diseases. This review systematically summarizes strategies to enhance PTT-mediated anti-inflammatory therapy through photothermal nanomaterials, with a particular focus on an emerging paradigm designed to achieve synergistic effects. This review begins with a categorical assessment of current research on inorganic and organic photothermal nanomaterials for anti-inflammatory applications. Building on this, we provide an in-depth analysis of disease-oriented PTT-based anti-inflammatory therapies (e.g. for vascular, articular, and periodontal inflammation), focusing on how engineering design, particularly targeted delivery and multimodal synergistic strategies, enables precise treatment in specific pathological models. Finally, we critically analyze the key challenges in this field, including photodynamic therapy (PDT) side effects, standardization of laser parameters, insufficient light penetration depth, clearance mechanisms, biosafety, and clinical translation. Prospective insights are also provided to guide the development of the next-generation intelligent and efficient photothermal nanoplatforms for anti-inflammatory therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.